The emergence of an unexpected or new strain of influenza means there are no prepared vaccines and the existing antivirals may be ineffective in combating the spread of infection. Vaccination is typically the first line of defense against influenza viruses [3] . The entire vaccine production process takes at least six months to complete [4] and although a pandemic (H1N1) 2009 vaccine became available in the U.S. in October 2009, there are severe shortages in the amount of vaccines available. Another concern is that the currently circulating H1N1 strain could mutate, making the vaccine ineffective or less effective.